VIA Pharmaceuticals, Inc. Stock Other OTC
Equities
VIAP
US92554T1034
Biotechnology & Medical Research
Financials (USD)
Sales 2009 | - | Sales 2010 | - | Capitalization | 822K |
---|---|---|---|---|---|
Net income 2009 | -21M | Net income 2010 | -9M | EV / Sales 2009 | - |
Net Debt 2009 | 7.81M | Net Debt 2010 | 13.92M | EV / Sales 2010 | - |
P/E ratio 2009 |
-0.19
x | P/E ratio 2010 |
-0.08
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 04-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 04-06-30 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |